| RVMD Revolution Medicines Inc. | 24.16% | 2,577,333 | $482.7M | No change |
| RLAY Relay Therapeutics Inc. | 15.02% | 16,035,240 | $300.0M | Add +11.2% |
| WGS Genedx Holdings Corp. | 12.74% | 3,707,164 | $254.5M | Add +23.3% |
| BLFS Biolife Solutions Inc. | 6.58% | 4,655,000 | $131.5M | Reduce -21.9% |
| ILMN Illumina Inc. | 4.66% | 530,000 | $93.2M | No change |
| LAB Standard Biotools Inc. | 3.66% | 88,783,856 | $73.0M | No change |
| GPCR Structure Therapeutics Inc. | 3.16% | 1,175,000 | $63.1M | No change |
| DNLI Denali Therapeutics Inc. | 2.63% | 2,045,000 | $52.6M | Add +11.1% |
| NGNE Neurogene Inc. | 2.43% | 1,545,361 | $48.6M | Add +8.8% |
| BEAM Beam Therapeutics Inc. | 2.32% | 1,350,000 | $46.3M | No change |
| TXG 10X Genomics Inc. Class A | 2.02% | 1,050,000 | $40.3M | Reduce -53.9% |
| SRRK Scholar Rock Holding Corp. | 1.83% | 665,000 | $36.6M | Add +90.0% |
| PSNL Personalis Inc. | 1.71% | 2,550,000 | $34.2M | Add +59.4% |
| GRAL Grail Inc. | 1.64% | 480,000 | $32.8M | Add +108.7% |
| GH Guardant Health Inc. | 1.39% | 185,000 | $27.8M | Reduce -41.3% |
| MAZE Maze Therapeutics Inc. | 1.26% | 843,857 | $25.2M | Add +11.2% |
| HIMS Hims & Hers Health Inc. | 1.21% | 700,000 | $24.3M | No change |
| ALNY Alnylam Pharmaceuticals Inc. | 1.13% | 75,000 | $22.6M | No change |
| TSHA Taysha Gene Therapies Inc. | 1.11% | 3,250,000 | $22.1M | No change |
| AGMB Agomab Therapeutics NV | 1.01% | 1,550,000 | $20.1M | No change |
| SEPN Septerna Inc. | 0.93% | 553,268 | $18.5M | No change |
| PBLS Parabilis Medicines Inc. | 0.88% | 645,690 | $17.7M | New |
| SION Sionna Therapeutics Inc. | 0.88% | 400,000 | $17.6M | New |
| VCYT Veracyte Inc. | 0.81% | 276,308 | $16.2M | No change |
| ANL Adlai Nortye Group Ltd. | 0.72% | 1,250,000 | $14.4M | Add +132.1% |
| PRME Prime Medicine Inc. | 0.58% | 3,167,175 | $11.7M | No change |
| ABSI Absci Corp. | 0.56% | 973,260 | $11.3M | No change |
| DGX Quest Diagnostics Inc. | 0.53% | 50,000 | $10.6M | No change |
| SRPT Sarepta Therapeutics Inc. | 0.42% | 470,000 | $8.4M | New |
| QURE Uniqure NV | 0.35% | 150,000 | $6.9M | New |
| NTLA Intellia Therapeutics Inc. | 0.30% | 355,000 | $6.0M | No change |
| MRNA Moderna Inc. | 0.26% | 75,000 | $5.3M | No change |
| IRON Disc Medicine Inc. | 0.24% | 65,000 | $4.8M | No change |
| GLUE Monte Rosa Therapeutics Inc. | 0.23% | 186,014 | $4.5M | No change |
| IPSC Century Therapeutics Inc. | 0.15% | 1,228,190 | $3.0M | No change |
| CTNM Contineum Therapeutics Inc. Class A | 0.12% | 148,333 | $2.4M | No change |
| BBOT Bridgebio Oncology Therapeut | 0.11% | 282,312 | $2.2M | No change |
| EDIT Editas Medicine Inc. | 0.07% | 445,000 | $1.4M | New |
| PACB Pacific Biosciences of Calif | 0.06% | 723,767 | $1.2M | No change |
| KARD Kardigan Inc. | 0.06% | 50,000 | $1.2M | New |
| RXRX Recursion Pharmaceuticals-A | 0.03% | 165,323 | $607K | No change |
| DNA Ginkgo Bioworks Holdings Inc. | 0.02% | 36,493 | $362K | No change |
| TNYA Tenaya Therapeutics Inc. | 0.01% | 361,969 | $268K | No change |